Zur Kurzanzeige

2012-07-20Zeitschriftenartikel DOI: 10.1016/j.vaccine.2012.07.012
Tools for cellular immunology and vaccine research the in the guinea pig: Monoclonal antibodies to cell surface antigens and cell lines
dc.contributor.authorSchäfer, Hubert
dc.contributor.authorBurger, Reinhard
dc.date.accessioned2018-05-07T17:05:08Z
dc.date.available2018-05-07T17:05:08Z
dc.date.created2013-10-16
dc.date.issued2012-07-20none
dc.identifier.otherhttp://edoc.rki.de/oa/articles/reEbF0Dicaw2/PDF/29WGCKuEBhWLI.pdf
dc.identifier.urihttp://edoc.rki.de/176904/1685
dc.description.abstractThe use of monoclonal antibodies directed against membrane proteins of leukocytes has greatly contributed to our understanding of the function and development of the immune system. Meanwhile these reagents provide valuable tools in many fields of research, stretching far beyond immunology and hematology. For guinea pigs only a limited number of such reagents have been described, and the information about availability and specificity is scattered over many years and journals. We provide an overview on the monoclonal antibodies produced since the technique was applied first in this species, with a focus on those reagents which have been characterized in more detail, and which should still be available either commercially or directly from the labs that created them.eng
dc.language.isoeng
dc.publisherRobert Koch-Institut
dc.subjectAnimalseng
dc.subjectCell Lineeng
dc.subjectAntigens CD/immunologyeng
dc.subjectAntibodies Monoclonal/immunologyeng
dc.subjectAntigens Surface/immunologyeng
dc.subjectGuinea Pigseng
dc.subjectImmunophenotyping/methodseng
dc.subjectLeukocytes/immunologyeng
dc.subject.ddc610 Medizin
dc.titleTools for cellular immunology and vaccine research the in the guinea pig: Monoclonal antibodies to cell surface antigens and cell lines
dc.typeperiodicalPart
dc.identifier.urnurn:nbn:de:0257-10033096
dc.identifier.doi10.1016/j.vaccine.2012.07.012
dc.identifier.doihttp://dx.doi.org/10.25646/1610
local.edoc.container-titleVaccine
local.edoc.container-textAUTHOR MANUSCRIPT. © Elsevier (2012): This is the author’s version of the work. It is posted here by permission of Elsevier for personal use, not for redistribution. Some changes resulting from the publishing process, such as editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Some changes may have been made to this work since being accepted for publication. A definitive version was subsequently published in Vaccine, [Volume: 30, Issue: 40, 2012 Jul 20]
local.edoc.fp-subtypeArtikel
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttp://www.sciencedirect.com/science/article/pii/S0264410X12010146
local.edoc.container-publisher-nameElsevier
local.edoc.container-volume30
local.edoc.container-issue40
local.edoc.container-year2012

Zur Kurzanzeige